Aileron Therapeutics Inc (NASDAQ:ALRN)
| 2.61 Delayed Data As of Dec 07 |  -0.0851 / -3.21%Today’s Change | 2.51 Today|||52-Week Range 15.00 | -76.82% Year-to-Date |
Latest ALRN News | Press Releases
No recent news for Aileron Therapeutics Inc.
Today’s Trading
| Previous close | 2.66 |
| Today’s open | 2.82 |
| Day’s range | 2.57 - 2.82 |
| Volume | 8,728 |
| Average volume (3 months) | 48,621 |
| Market cap | $12.8M |
Data as of 3:28pm ET, 12/07/2022
Growth & Valuation
| Earnings growth (last year) | +51.45% |
| Earnings growth (this year) | -9.92% |
| Earnings growth (next 5 years) | +2.06% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMRNImmuron Ltd | +0.02 | +0.79% |
| VYNEVyne Therapeutics In... | -0.01 | -2.82% |
| ---- | ||
| NRBONeurobo Pharmaceutic... | +0.31 | +22.30% |
Data as of 3:19pm ET, 12/08/2022
Financials
| Next reporting date | April 3, 2023 |
| EPS forecast (this quarter) | -$1.32 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$26.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
